Baf57 is a potential determinant of colorectal cancer malignancy

HIROFUMI SUZUMURA, MASASHI TSURUTA, KOJI OKABAYASHI, KOHEI SHIGETA, RYO SEISHIMA, TAKASHI ISHIDA, TAKEHIRO SHIMADA, YUSUKE ASADA, KAORU KOISHIKAWA, SHINGO AKIMOTO, OSAMU ITANO, HIROTOSHI HASEGAWA, YUKO KITAGAWA

研究成果: Article査読

抄録

Background/Aim: The role of brahma-related gene 1 (BRG1)-associated factor 57 (BAF57), a transcription factor, has been determined in prostate, breast, and ovarian cancer. However, the relationship between BAF57 and colorectal cancer (CRC) is obscure. Thus, we examined the functional correlation between BAF57 expression and oncological malignancy in CRC in vitro. Materials and Methods: BAF57 expression in WiDr and HT29 CRC cell lines and clinical specimens from CRC patients was analysed by western blotting and/or RT-PCR. BAF57 expression was down-regulated in WiDr cells through siRNA transfection. An invasion assay was also performed to assess malignancy. Results: BAF57 was expressed in both human CRC cell lines. Overall survival and recurrence-free survival rates were significantly reduced in high BAF57-expressing specimens. BAF57 expression was an independent predictive factor for long-term survival. Conclusion: BAF57 correlates with oncological malignancy and may be a novel therapeutic target in CRC.

本文言語English
ページ(範囲)5445-5452
ページ数8
ジャーナルAnticancer research
41
11
DOI
出版ステータスPublished - 2021 11

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「Baf57 is a potential determinant of colorectal cancer malignancy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル